HIV mutation literature information.


  Food and Drug Administration analysis of tipranavir clinical resistance in HIV-1-infected treatment-experienced patients.
 PMID: 17197808       2007       AIDS (London, England)
Abstract: The most common protease mutations that developed in tipranavir-treated individuals who experienced virologic failure were L10I/V/S, I13V, L33V/I/F, M36V/I/L V82T, V82L, and I84V.


  Effects of drug resistance on viral load in patients failing antiretroviral therapy.
 PMID: 16555280       2006       Journal of medical virology
Abstract: Certain reverse transcriptase mutations such as M184V/I, K70R, V108I, and protease mutations such as L33FIV, M84V, and M36I were associated with reduced viral load.



Browser Board

 Co-occurred Entities




   Filtrator